Clinical Trial Update: Temozolomide and Radiation Therapy With or Without Vatalanib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial evaluated temozolomide with radiation therapy, with and without the VEGF inhibitor vatalanib, in newly diagnosed glioblastoma multiforme; the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma Multiforme

Drugs mentioned

• Temozolomide (Temozolomide)
• Vatalanib (vatalanib)

Snippet

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC | Conditions: Brain and Central Nervous System Tumors | Phase 1, Phase 2 | Status: COMPLETED